Shares of other companies:
April 27, 2024 Alphabet and Microsoft’s AI Investments Yield Strong Returns
April 26, 2024 Top 10 High Dividend Yield Stocks
Tesla Q1: Model 2 Could Be Their Model T
April 25, 2024
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
April 12, 2024 Improve Your Financial Status: A How-To Guide
Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…
MNOV Stock News and Mentions of MediciNova, Inc. Stocktwits
Updated: April 28, 2024 (09:14)
Sector: Healthcare
Welcome to PandaPulse, innovative analytical stock market observer, where the latest news and stocktwits meets in-depth investor relations insights. Dive into our real-time sentiment analysis to gauge the mood of the markets and arm yourself with key information that resonates with both savvy investors and casual traders.
We meticulously analyze the sentiment trend in each article for the last 60 days where MediciNova Company is mentioned. We assess its relevance and importance to carry out an overall sentiment valuation of MediciNova, Inc. (MNOV).
You can view the trend designation for each individual article below. We use this data to compile indicators into one comprehensive sentiment value, which represents the current information agenda about the MediciNova stocks.
Please wait, while the data is preparing...
General evaluation of the current information agenda's sentiments
Agenda Trend
Analyzed articles
News and Mentions of MediciNova, Inc. (MNOV)
April 21, 2024 (14:16) / "Stocknews.com" (by Defense World Staff)
StockNews.com Begins Coverage on MediciNova ( NASDAQ:MNOV )
Equities research analysts at StockNews.com began coverage on shares of MediciNova ( NASDAQ:MNOV - Get Free Report ) in a report issued on Sunday. The firm set a "hold" rating on the biopharmaceutical company's stock. Shares of NASDAQ MNOV opened at $1.39 on Friday.
In Article Trend: Somewhat-Bullish
April 13, 2024 (06:22) / "Stocknews.com" (by Defense World Staff)
MediciNova ( NASDAQ:MNOV ) Now Covered by Analysts at StockNews.com
Investment analysts at StockNews.com started coverage on shares of MediciNova ( NASDAQ:MNOV - Get Free Report ) in a research note issued to investors on Saturday. The brokerage set a "hold" rating on the biopharmaceutical company's stock. MNOV stock opened at $1.57 on Friday.
In Article Trend: Somewhat-Bullish
April 5, 2024 (06:16) / "Stocknews.com" (by Defense World Staff)
MediciNova ( NASDAQ:MNOV ) Now Covered by Analysts at StockNews.com
Research analysts at StockNews.com assumed coverage on shares of MediciNova ( NASDAQ:MNOV - Get Free Report ) in a note issued to investors on Friday. The brokerage set a "hold" rating on the biopharmaceutical company's stock. Shares of MNOV opened at $1.46 on Friday.
In Article Trend: Somewhat-Bullish
April 2, 2024 (23:00) / "Benzinga" (by Globe Newswire)
MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 ( ibudilast ) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting ( 2024 ASCO ) - MediciNova ( NASDAQ:MNOV )
LA JOLLA, Calif., April 02, 2024 ( GLOBE NEWSWIRE ) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market MNOV and the Standard Market of the Tokyo Stock Exchange ( Code Number: 4875 ) , today announced that an abstract regarding results of a clinical trial of ...
In Article Trend: Neutral
April 2, 2024 (23:00) / "GlobeNewswire" (by MediciNova)
MediciNova Announces Abstract Regarding Results of a Clinical Trial of MN-166 ( ibudilast ) in Glioblastoma Accepted for Presentation at the 2024 American Society of Clinical Oncology Annual Meeting ( 2024 ASCO )
LA JOLLA, Calif., April 02, 2024 ( GLOBE NEWSWIRE ) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market ( NASDAQ:MNOV ) and the Standard Market of the Tokyo Stock Exchange ( Code Number: 4875 ) , today announced that an abstract regarding results of a clinical ...
In Article Trend: Neutral
March 28, 2024 (06:24) / "Stocknews.com" (by Defense World Staff)
MediciNova ( NASDAQ:MNOV ) Earns Hold Rating from Analysts at StockNews.com
Equities researchers at StockNews.com initiated coverage on shares of MediciNova ( NASDAQ:MNOV - Get Free Report ) in a research report issued to clients and investors on Thursday. The firm set a "hold" rating on the biopharmaceutical company's stock. Shares of MediciNova stock opened at $1.47 ...
In Article Trend: Somewhat-Bullish
March 27, 2024 (12:14) / "Benzinga" (by Avi Kapoor)
Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket - MariaDB ( NYSE:MRDB )
Shares of MariaDB plc MRDB rose sharply in today's pre-market trading after Progress Software PRGS announced that it is possibly considering an offer for the company. MariaDB shares jumped 100.4% to $0.4530 in pre-market trading Here are some other stocks moving in pre-market trading.
In Article Trend: Somewhat-Bullish
March 26, 2024 (23:00) / "Benzinga" (by Globe Newswire)
MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 ( ibudilast ) for the Treatment of Macular Injury in Japan - MediciNova ( NASDAQ:MNOV )
LA JOLLA, Calif., March 26, 2024 ( GLOBE NEWSWIRE ) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market MNOV and the Standard Market of the Tokyo Stock Exchange ( Code Number: 4875 ) , today announced it has received a Notice of Allowance from the Japan Patent ...
In Article Trend: Neutral
March 26, 2024 (23:00) / "GlobeNewswire" (by Inc.)
MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 ( ibudilast ) for the Treatment of Macular Injury in Japan
LA JOLLA, Calif., March 26, 2024 ( GLOBE NEWSWIRE ) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market ( NASDAQ:MNOV ) and the Standard Market of the Tokyo Stock Exchange ( Code Number: 4875 ) , today announced it has received a Notice of Allowance from the Japan ...
In Article Trend: Neutral
March 20, 2024 (23:00) / "Benzinga" (by Globe Newswire)
MediciNova Announces Two Abstracts regarding MN-001 ( tipelukast ) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society - MediciNova ( NASDAQ:MNOV )
LA JOLLA, Calif., March 20, 2024 ( GLOBE NEWSWIRE ) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market MNOV and the Standard Market of the Tokyo Stock Exchange ( Code Number: 4875 ) , today announced that two abstracts entitled "STUDY PROTOCOL TO EVALUATE ...
In Article Trend: Neutral
March 20, 2024 (23:00) / "GlobeNewswire" (by MediciNova)
MediciNova Announces Two Abstracts regarding MN-001 ( tipelukast ) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society
LA JOLLA, Calif., March 20, 2024 ( GLOBE NEWSWIRE ) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market ( NASDAQ:MNOV ) and the Standard Market of the Tokyo Stock Exchange ( Code Number: 4875 ) , today announced that two abstracts entitled "STUDY PROTOCOL TO ...
In Article Trend: Neutral
March 20, 2024 (07:30) / "Stocknews.com" (by Defense World Staff)
MediciNova ( NASDAQ:MNOV ) Now Covered by Analysts at StockNews.com
Analysts at StockNews.com assumed coverage on shares of MediciNova ( NASDAQ:MNOV - Get Free Report ) in a research note issued to investors on Wednesday. The firm set a "hold" rating on the biopharmaceutical company's stock. NASDAQ MNOV opened at $1.32 on Wednesday.
In Article Trend: Somewhat-Bullish
March 12, 2024 (10:30) / "Benzinga" (by Globe Newswire)
MediciNova Announces New Data and Results of MN-166 ( ibudilast ) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of Toxicology - MediciNova ( NASDAQ:MNOV )
LA JOLLA, Calif., March 12, 2024 ( GLOBE NEWSWIRE ) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market MNOV and the Standard Market of the Tokyo Stock Exchange ( Code Number: 4875 ) , today announced that MediciNova's collaborator, Perenlei Enkhbaatar, MD, PhD, ...
In Article Trend: Neutral
March 12, 2024 (10:30) / "GlobeNewswire" (by MediciNova)
MediciNova Announces New Data and Results of MN-166 ( ibudilast ) in Chlorine Gas-induced Acute Lung Injury Presented at the 63rd Annual Meeting of the Society of Toxicology
LA JOLLA, Calif., March 12, 2024 ( GLOBE NEWSWIRE ) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market ( NASDAQ:MNOV ) and the Standard Market of the Tokyo Stock Exchange ( Code Number: 4875 ) , today announced that MediciNova's collaborator, Perenlei Enkhbaatar, ...
In Article Trend: Neutral
March 12, 2024 (06:34) / "Stocknews.com" (by Defense World Staff)
MediciNova ( NASDAQ:MNOV ) Now Covered by Analysts at StockNews.com
Research analysts at StockNews.com assumed coverage on shares of MediciNova ( NASDAQ:MNOV - Get Free Report ) in a note issued to investors on Tuesday. The brokerage set a "hold" rating on the biopharmaceutical company's stock. Shares of NASDAQ MNOV opened at $1.38 on Tuesday.
In Article Trend: Somewhat-Bullish
March 4, 2024 (07:48) / "Stocknews.com" (by Defense World Staff)
MediciNova ( NASDAQ:MNOV ) Research Coverage Started at StockNews.com
Stock analysts at StockNews.com started coverage on shares of MediciNova ( NASDAQ:MNOV - Get Free Report ) in a report issued on Monday. The brokerage set a "hold" rating on the biopharmaceutical company's stock. Shares of NASDAQ:MNOV opened at $1.35 on Monday.
In Article Trend: Somewhat-Bullish
Related stocks from Healthcare sector
This website uses cookies to ensure you get the best experience on our website